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ABSTRACT  
Objective: Natural language processing can help minimize human intervention in identifying patients 
meeting eligibility criteria for clinical trials, but there is still a long way to go to obtain a general and 
systematic approach that is useful for researchers. We describe two methods taking a step in this 
direction and present their results obtained during the n2c2 challenge on cohort selection for clinical 
trials. 
Materials and Methods: The first method is a weakly supervised method using an unlabeled corpus 
(MIMIC) to build a silver standard, by producing semi-automatically a small and very precise set of 
rules to detect some samples of positive and negative patients. This silver standard is then used to 
train a traditional supervised model. The second method is a terminology-based approach where a 
medical expert selects the appropriate concepts, and a procedure is defined to search the terms and 
check the structural or temporal constraints.  
Results: On the n2c2 dataset containing annotated data about 13 selection criteria on 288 patients, we 
obtained an overall F1-measure of 0.8969, which is the third best result out of 45 participant teams, 
with no statistically significant difference with the best-ranked team. 
Discussion: Both approaches obtained very encouraging results and apply to different types of 
criteria. The weakly supervised method requires explicit descriptions of positive and negative 
examples in some reports. The terminology-based method is very efficient when medical concepts 
carry most of the relevant information. 
Conclusion: It is unlikely that much more annotated data will be soon available for the task of 
identifying a wide range of patient phenotypes. One must focus on weakly or non-supervised learning 
methods using both structured and unstructured data and relying on a comprehensive representation 
of the patients. 
 
1. INTRODUCTION  
Identifying patients sharing common clinical or biological characteristics (phenotyping) is of great 
importance in medical research [1, 2]. Phenotyping in electronic health patient records (EHRs) offers 
the possibility of phenome-wide association scans (PheWAS) for disease-gene associations [3, 4, 5]. 
Phenotyping plays also an important role in feasibility study and patient recruitment in clinical trials. 
The process of eligibility determination is extremely challenging and time-consuming, mandating 
most of the time manual chart review. Clinical Trial Recruitment Support Systems aim to automate 
this process in healthcare settings. Initially based on non-scalable, system- or vendor-specific efforts, 
eligibility determination is now provided by large scale platforms querying patient data from 
federated EHR systems from many different sites in different countries [6, 7, 8]. Numerous work has 
been carried out to formalize and classify eligibility criteria in order to automate patient eligibility 
determination [9, 10, 11, 12]. The Phenotype KnowledgeBase database contains rule-based 
phenotype definitions incorporating coded concepts (using SNOMED, LOINC, ICD10, etc.) [13]. 
However, rule-based definitions based on heterogeneous structured data such as diagnosis codes, 
laboratory results, medication orders or problem lists are difficult to share across different EHR 
systems. Moreover, the criteria, specified in natural language, can be of an extremely different nature, 
and some criteria require very specific medical knowledge, elaborate reasoning or subjective 
judgment. The notes, that still remain the preferred means of documentation for physicians, frequently 
contain personal or clinical information that the structured data does not, and that are critical for 
eligibility determination [14]. Thus, the use of clinical notes from the EHR is imperative for eligibility 
determination [15, 16], but there is still no effective and general approach for identifying patients 
who validate multiple and varied selection criteria from the text. It is also impossible to build 
annotated datasets for all possible criteria, which disqualifies the traditional supervised learning 
approaches. Early work has applied partially supervised methods using the text of the reports to try 
to generalize the process [17, 18, 19]. 
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In this paper, we present two methods for minimizing the human intervention in the cohort selection: 
an approach using weak supervision to build a big “silver standard” dataset suitable for supervised 
learning, and a terminology-based approach where a medical expert selects the appropriate concepts. 
This work has been done in the framework of the n2c2 challenge on cohort selection for clinical trials1 
and the results presented here are the official results obtained for this challenge. This challenge aimed 
at investigating how the state of the art of natural language processing could be used to identify 
patients meeting selection criteria for clinical trials, by using only the text of the EHRs. The organizers 
chose 13 varied and realistic selection criteria, and the task was to design a system determining, from 
several textual reports on a given patient, whether this patient was eligible or not to each of these 13 
criteria. More details on the criteria and the task are given at Section 3.1. 
 
2. RELATED WORK 
Many statistical approaches to natural language processing (NLP) have recently been proposed to 
exploit the texts of patient records to allow the identification of phenotypes [20, 21, 22, 23, 24, 25, 
26, 27]. Most of these methods fall under the category of fully supervised learning. These models 
require the creation of a manually annotated dataset (by human experts) to allow the training of a 
statistical model, which can then be applied to new data. These approaches therefore require a 
considerable initial investment, and are difficult to generalize because the manual annotations are 
specific to a particular case [28, 25]; this is the reason why they have only been applied to a relatively 
limited number of phenotypes. 
More recently, “weakly supervised” approaches have been proposed, making it possible to partially 
overcome the manual annotation step by building semi-automatically a larger dataset, but generally 
noisy or of lower quality. Weak supervision is a generic term for a set of approaches where labeled 
data is obtained by means other than full manual annotation. One of these means is “active” learning, 
in which the files proposed to the expert are automatically selected so as to minimize the number of 
patients to explore before obtaining a good quality training dataset [28]. Other methods imply a semi-
automatic annotation of an unlabeled corpus with predefined terms or rules [17, 18, 19], which can 
be enriched with a bootstrapping algorithm. These latter works are the closest to what we propose in 
Section 4.2. To the best of our knowledge, other weakly supervised paradigms such as distant 
supervision [29] or knowledge transfer [30] have not yet been applied specifically to classifying 
eligibility criteria.  
 
3. MATERIAL 
This section describes the n2c2 corpus as well as other resources that we used for building our 
different systems. 
3.1 n2c2 Corpus for Cohort Selection for Clinical Trials 
We used the corpus from the n2c2 challenge on cohort selection for clinical trials, for development 
and evaluation. This corpus has been made available to the 45 participant teams of the challenge in 
2018, and is composed of 1,267 reports in English, concerning 288 patients (between 2 and 5 
documents per patient). Only the textual content of the reports is available. All patients have diabetes, 
most of them are at risk for heart disease. Each patient record is annotated by two medical experts 
who assigned to this patient a “meets” or “does not meet” status for each of the following 13 criteria: 
 ABDOMINAL (History of intra-abdominal surgery, intestine resection or small bowel 
                                                 
1 https://n2c2.dbmi.hms.harvard.edu/track1 
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obstruction) 
 ADVANCED-CAD (Advanced cardiovascular disease – two or more of 4 sub-criteria defined 
in the guidelines) 
 ALCOHOL-ABUSE (Current alcohol use over weekly recommended limits) 
 ASP-FOR-MI (Use of aspirin to prevent myocardial infarction) 
 CREATININE (Serum creatinine > upper limit of normal) 
 DIET-SUPP (Taken a dietary supplement (excluding Vitamin D) in the past 2 months) 
 DRUG-ABUSE (Drug abuse, current or past) 
 ENGLISH (Patient must speak English) 
 HBA1C (Any HbA1c value between 6.5 and 9.5%) 
 KETO-1YR (Diagnosis of ketoacidosis in the past year) 
 MAJOR-DIABETES (Major diabetes-related complication – among 6 complications listed in the 
guidelines) 
 MAKES-DECISION (Patient must make their own medical decisions) 
The overall agreement between the two annotators before adjudication was 84.9% (overlap between 
two annotations).  
These 288 patients are split between a training set of 202 patients and a test set of 86 patients. The 
latter has been provided to the participants during the test phase in May 2018. Table 1 provides more 
details about the corpus and Erreur ! Source du renvoi introuvable. shows the distribution of the 
“met” and “not met” classes. 
 
 
 
 Training set Test set Total 
Patient number 202 86 288 
Document number 890 377 1267 
Mean documents par patient 4.41 4.38 4.40 
Token number (approx.) 700k 300k 1M 
Table 1. n2c2 corpus general statistics. 
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Figure 1. Distribution of the classes "met" and "not met" for the 13 criteria of the n2c2 corpus. 
 
3.2 Other resources 
 The Unified Medical Language System (UMLS) metathesaurus [31] comprises over 1 million 
biomedical concepts and 5 million concept names (mostly in English) from over 
100 controlled vocabularies, including SNOMED CT which have been our main resources. 
We used UMLS to collect the medical concepts on interest in our terminology-based 
approach. 
 MIMIC is a large, freely-available database comprising deidentified health-related data 
associated with over 40,000 patients [32]. We used the 2 million MIMIC clinical notes in 
English in order to compute word embeddings and augment our training set (semi-supervised 
approach) or find new rules (semi-supervised and rule-based approaches). 
 
4.  METHODS 
We consider the task as 13 independent binary classification problems: given a set of several textual 
documents from a patient’s records, and for each of the criteria described in Section 3.1, our system 
has to decide whether the patient meets or does not meet the criterion.   
Current methods used in research for text classification are based on supervised machine learning 
(ML), i.e. algorithms automatically learning on the training set how to classify the patient and to 
generalize on unseen patients from the test set. However, some characteristics of this dataset make 
this approach a bad candidate for producing good results: 
 Very limited amount of data available for training 
 Difficult, ambiguous task requiring expert (medical) knowledge  
 Highly unbalanced classes for some of the criteria (i.e. one of the two classes “met” or “not 
met” is very infrequent, such as ketoacidosis diagnosis or not being able to make medical 
decision, as illustrated by Erreur ! Source du renvoi introuvable.). This represents a major 
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obstacle for most ML algorithms. 
 Temporal dimension present for some criteria (e.g. ketoacidosis diagnosis in the past year, 
current alcohol abuse, dietary supplement in the past 2 months). This dimension is very hard 
to represent in a general representation for ML systems. 
On the other hand, rule-based approaches are good candidates, but do not generalize well, which 
means that the 13 criteria would require 13 different hand-crafted sets of rules. 
In an effort for generalizing the process of finding patients matching eligibility criteria, we 
investigated two methods for minimizing the human intervention: a semi-supervised approach aiming 
at building a big “silver standard” dataset suitable for supervised learning (Section 4.2) and a 
terminology-based approach where a medical expert selects the appropriate concepts (Section 4.3). 
Finally, some criteria were solved by a specific rule-based approach (Section 4.4). We first describe 
the different tools that we used to process the text (Section 4.1). 
4.1 Text processing 
We describe here the tools that we used in one or more of our systems for processing the text at 
different levels: tokenization, cleaning, normalization, structure extraction.  
 Stanford CoreNLP [33] is a set of human language technology tools for 7 languages, not 
specialized in clinical texts but very robust; we used it for sentence splitting and word 
tokenization, in all our systems. 
 Apache cTAKES [34] is an NLP system specialized in information extraction from medical 
record clinical free-text in English. We used it for detecting concepts that are negated or 
uncertain in the notes in our terminology-based approach. We also extended the negation 
detection with a few rules that were very frequent in our corpus. 
 HeidelTime [35] is a multilingual and cross-domain temporal tagging tool. We used it for 
the few temporally constraint criteria, for detecting and normalizing dates present in the text 
(e.g. “last June” in an article written in December 2018 is converted into the absolute date 
“June 2018”, etc.). 
 Spelling correction. We looked for spelling mistakes and typos for all the concepts searched 
in our terminology-based approach. We learned a word2vec model [36] on the MIMIC clinical 
notes [32]. Word2vec produces vectors for each token found in the corpus; similar vectors 
(based here on a cosine similarity metric) correspond to words that share the same context and 
have a strong semantic relationship with each other (synonymy, antonyms, cohyponymy or 
another semantic relation). For each concept word w within UMLS having more than three 
letters, we listed its 200 most similar words and kept those having a Levenshtein distance 
lower than 2 with w. All these words are considered as synonymous with w.    
 Section splitter. Most medical documents contain some sections (e.g.: Family History, 
Medication...) which are often introduced by a few words ended with a newline or/and a colon. 
Based on this pattern we automatically extracted candidates from n2c2 and MIMIC 
documents and only kept most frequent (frequency > 1%). We got a total set of 1455 section 
titles. Based on those textual labels, we applied a regular expression pipeline to separate the 
documents into sections. 
 
We now describe the different methods we used to classify the patients according to the 13 eligibility 
criteria. 
4.2 Weakly supervised methods 
The idea underlying this first approach is to massively augment the training data with the help of the 
MIMIC database, which contains more than 2 million unlabeled clinical notes for more than 40,000 
patients. The three criteria concerned by this approach are: 
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 ALCOHOL-ABUSE (Alcohol use over weekly recommended limits) 
 DRUG-ABUSE (Drug abuse, current or past) 
 KETO-1YR (Diagnosis of ketoacidosis in the past year) 
Erreur ! Source du renvoi introuvable. illustrates the process with the example of ALCOHOL-ABUSE. 
From the n2c2 dataset, we have produced semi-automatically (automatic extraction and manual 
review and correction) a small and very precise set of rules to detect without ambiguity some samples 
of positive ("met") or negative ("not met") patients (step  in the figure). Examples of positive and 
negative rules for ALCOHOL-ABUSE and DRUG-ABUSE are given at Table 2; note that positive examples 
are discarded when found in the context of a negation (“no history of”, “denies”, etc.). Being very 
specific, these rules are expected to have a high precision but a very bad coverage (recall), because 
of the high linguistic variation that can be observed in the reports. However, applied to a big corpus 
such as MIMIC, these rules are enough to collect a large number of patients (ALCOHOL-ABUSE: 13,000 
negative, 1,500 positive ; DRUG-ABUSE: 6,100 negative, 2,000 positive) (step ). As these patients 
are often associated to many reports, our hypothesis is then that expressions other than the seed rules 
will be used for describing the same problem (alcohol, drug abuse, ketoacidosis diagnosis) through 
the patient’s file, leading to a large and varied training corpus. Such a corpus, built semi-
automatically, is called a silver standard, as opposed to a gold standard verified and validated by 
human experts. Similar rules have been created for DRUG-ABUSE, while we used the ICD-9 
ketoacidosis diagnosis code for KETO-1YR (250.1 and children). 
 
 
Figure 2. Examples of trigger rules for alcohol-abuse. 
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ALCOHOL-ABUSE 
Positive rules Negative rules 
“drinks heavily” 
“alcoholism” 
“alcohol abuse” 
“binge drinking” 
“drinking episodes” 
“etoh” 
(20 rules total) 
“denies […] alcoholic beverage abuse” 
“no alcohol in * (years|yrs)” 
“clean.{1,40} (alcohol|etoh)” 
“alcohol use status: moderate” 
“etoh: social”, 
etc. 
(40 rules total) 
DRUG-ABUSE 
Positive rules Negative rules 
“uses { DRUG_NAMES }” 
“used { DRUG_NAMES } ” 
“consumed { DRUG_NAMES }” 
“previous use of { DRUG_NAMES }” 
“history of { DRUG_NAMES }” 
With DRUG_NAMES a set containing [“marijuana”, 
“cocaine”, “heroin”, “crack”, “ivdu”, etc.](32 names 
total ~ 200 rules) 
“never used(?={DRUG_NAMES})” 
“clean.{1,40} {DRUG_NAMES}” 
“no.*drug use.*history” 
“negative for.{0,30} {DRUG_NAMES}” 
“(?={DRUG_NAMES})(?=(son|brother|etc.)) 
(180 rules total) 
 
Table 2: Examples of trigger rules for ALCOHOL-ABUSE. 
 
This silver standard, together with the n2c2 training data (gold standard) can then be used to train a 
classical supervised classification system, with enough data to expect good results. In our case, for 
DRUG-ABUSE and ALCOHOL-ABUSE, we applied two learning models (step ): the deep learning 
classifier FastText [37] using embeddings pre-trained on MIMIC, and a simple logistic regression 
based on a tf.idf transformation of the words. The final prediction is provided by another logistic 
regression on the predictions of the first two models. For KETO-1YR, which had no positive example 
in the training data, we choose a simpler random forest algorithm which finally correctly predicted 
zero positive example in the test data as well. 
Note that all these fully supervised training systems need both positive and negative examples for 
their training. For this reason, an effective weakly-supervised approach requires that positive and 
negative rules can be written, which is actually quite rare, as will be noticed in next sections and 
discussed in Section 5. 
 
4.3 Terminology-based methods 
Our second effort to generalize the process of cohort selection applies to criteria for which medical 
knowledge is important and the presence of specific medical concepts in the texts is crucial to decide 
about eligibility. We identified six criteria having these characteristics: 
 ABDOMINAL (History of intra-abdominal surgery, intestine resection or small bowel 
obstruction) 
 ADVANCED-CAD (Advanced cardiovascular disease) 
 ASP-FOR-MI (Use of aspirin to prevent myocardial infarction) 
 DIET-SUPP (Taken a dietary supplement (excluding Vitamin D) in the past 2 months) 
 MAJOR-DIABETES (Major diabetes-related complication) 
 MI-6MOS (Myocardial infarction in the past 6 months) 
For all these cases, negative (“not met”) situations are rarely explicit in the documents: the text does 
almost never specify that the patient has not taken any dietary supplement or has had no myocardial 
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infarction, and so on. That is why we were not able to apply a semi-supervised strategy as described 
in previous section. Instead, we applied a concept-matching approach based on the following steps: 
1. Terminology: use UMLS to collect descendants and synonyms of concepts corresponding to 
the inclusion criteria, as defined by medical experts in the team. 
2. Spelling correction: apply our word2vec-based spell checker. 
3. Negation, uncertainty: use cTAKES [34] and our extra rules to discard negated or uncertain 
events in text (e.g. “The patient is being evaluated for renal transplant” or “discussed 
possibility of gastric bypass” for ABDOMINAL, “she has no evidence of neuropathy at this time” 
for MAJOR-DIABETES). 
4. Structure: restrict the concept search to specific sections, as defined either by medical experts 
or by an automatic selection of relevant sections within the training data. For example, 
“calcium” is a dietary supplement if found in a “Medication” section, but not in a “laboratory 
result” section. 
5. Temporal dimension: if specified in the description, restrict to recent reports or to sentences 
containing a date within the inclusion date range (with HeidelTime [35]). E.g.: “gentleman 
who had an MI in June 2017” for the class MI-6MOS. 
The final step is to trigger a “met” decision as soon as at least one relevant term is found in the text. 
This process requires a significant human investment, but less than an exclusively rule-based 
approach. 
4.3.1 Example: ABDOMINAL 
For this criterion, positive patients must have a history of intra-abdominal surgery, small or large 
intestine resection or small bowel obstruction. Hernia are explicitly excluded from this definition. 
Based on this description, we collected all descendants of the concept “Operation on abdominal 
region” (CUI C0198482) in the UMLS, as well as “small bowel obstruction”, “stomach bypass”, 
“hysterectomy”, “cholecystectomy”, and we excluded 19 CUIs containing the word “hernia”, as well 
as noisy terms having very common homonyms in the training corpus (“apr”, “turp”, “tips”, “sch”). 
This led to a list of 17,703 terms that were systematically searched for in the texts. Negated or 
uncertain terms were discarded. Each patient file containing at least one of these terms was labeled 
as “met”. 
4.3.2 Example: DIET-SUPP 
For this criterion, positive patients must have taken a dietary supplement (excluding Vitamin D) in 
the past 2 months. We collected a list of 183 ingredients listed as dietary supplements in different 
resources and mapped this list to the records created between “now” (for the challenge, “now” was 
the date of the last report for the patient) and 2 months before. We looked only in the sections 
involving new medications. 
4.3.3 Example: ADVANCED-CAD 
The guidelines define “advanced” as having two or more of the following: 
 Taking two or more medications to treat CAD. The CAD medication list was built from the 
structured prescription tables of MIMIC, as the difference between the medications prescribed 
for general coronary diseases (ICD9 in 410, 411, 412, 413) and the others. We manually 
reviewed the result and extended it with medications from NHS guidelines2 to result in a 40 
entry list. 
                                                 
2 https://www.nwcscnsenate.nhs.uk/files/9014/5642/1864/CMSCN_NSTEMI_ACS_Guideline_Final_2016.pdf 
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 History of myocardial infarction. Met when “infarction”, “stemi” and synonyms are present 
except together with other organs than heart and excluding sections specific to neuro imaging. 
 Currently experiencing angina. Met when “angina” or synonyms is present with no date or 
together with a date in the same sentence which is less than 6 months old. 
 Ischemia, past or present. Met when “ischemia” or synonyms is present. 
 
4.4 Rule-based methods 
Within the n2c2 dataset, 4 criteria unfortunately escape the generalization efforts and require the 
implementation of dedicated rules: 
 CREATININE (Serum creatinine > upper limit of normal) 
 HBA1C (Any HbA1c value between 6.5 and 9.5%) 
 ENGLISH (Patient must speak English) 
 MAKES-DECISION (Patient must make their own medical decisions) 
 
The first two are lab results that can be extracted quite easily from tables or free text, with little 
variations. Each one required no more than 15 basic regular expressions. We used the annotated 
training data to determine the “upper limit of normal” for creatinine, finally set to 1.5 mg/dL 
(disregarding the male or female status of the patient), which is above the usual recommendations3. 
 
ENGLISH and MAKES-DECISION are much more difficult because of three main reasons: 
 Data is highly unbalanced (most patients can make their own decisions and speak English in 
this U.S. dataset, see Erreur ! Source du renvoi introuvable.). 
 Negative examples are implicit (the report will not mention that the patient can make their 
decisions or speak English), making our semi-supervised approach impossible to set up. 
 There is an infinity of possible variations to express the fact that a patient is unable to speak 
English or make decisions (e.g. a long anecdote leading to the implicit conclusion that the 
patient is mentally too confused to meet the criterion). 
For these reasons, rules currently seem to be the only way to go. We built a set of weighted positive 
and negative rules around the idea that a patient could speak another language, need a translator or 
not understand English (ENGLISH, 55 rules), or have dementia, mental retardation, be unable to answer 
questions or under tutorship or curatorship (MAKES-DECISION, 67 rules).  
5. RESULTS  
During the n2c2 challenge, our different systems have been evaluated by the organizers on the 86 
patients from the test set, using the traditional metrics precision, recall and F1-measure (harmonic 
mean of precision and recall). Table 3 reproduces these results, together with the support for each 
class (number of “met”/“not met” patients). Following the official global metric of the challenge 
(micro F1-measure of 0.8969), we achieved the third best result out of 45 participant teams, with no 
statistically significant difference4 with the best-ranked team (Medical University of 
Graz –  F1 0.9100) that applied a dedicated rule-based system to each criterion. 
                                                 
3 1.0 mg/dL for females and 1.2 mg/dL for males. 
4 As reported by the organizers. 
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Table 3. Our official results at n2c2 challenge. 
 
6. DISCUSSION 
The scores presented at previous section are encouraging, even though one must be very careful when 
interpreting results for some criteria supported by only few positive or negative examples. The 
terminology-based approach obtained very good results, except for ASP-FOR-MI where some more 
reasoning is probably necessary. The weakly-supervised approach led to coherent results, showing 
that this lead is worth being followed. Its limits should also be further investigated: first, we must 
work on evaluating and reducing the noise and possible bias introduced by the method used to collect 
the silver standard. Second, we pointed out that finding negative examples was the trickiest issue with 
this approach. In previous work, Agarwal et al. [18] build a silver standard in which positive and 
negative examples are documents where some predefined terms are respectively present and absent. 
Halpern et al. [17] find only positive examples and apply Positive-Unlabeled learning algorithm [38] 
to build their silver standard. These approaches would generalize to more cases but generate noisier 
datasets. 
It is therefore notable that the different existing approaches apply to different categories of criteria, 
which must be identified in advance: a terminological approach (Section 4.3) when only medical 
terms are manipulated and the presence of or the absence of certain concepts is generally sufficient 
to discriminate between positive and negative examples; a weakly supervised approach seeking 
                                                 
5 Note that the official evaluation script attributed the erroneous precision and recall of 0 for "met" on KETO-1YR, due to 
the fact that there was no "met" in the test set. This value is then different than the official one. 
 
Criterion 
Met Not met Overall 
F1 Approach Sup. Prec. Rec. F1 Sup. Prec. Rec. F1 
Semi-
supervised 
ALCOHOL 3 1.00 0.33 0.50 83 0.98 1.00 0.99 0.74 
DRUG 3 0.67 0.67 0.67 83 0.99 0.99 0.99 0.83 
KETO-1YR 0 -5 -5 -5 86 1.00 1.00 1.00 1.005 
Terminology-
based 
ABDOMINAL 30 0.85 0.93 0.89 56 0.96 0.91 0.94 0.91 
ADV.-CAD 45 0.74 0.87 0.80 41 0.82 0.66 0.73 0.76 
ASP-FOR-MI 68 0.83 0.91 0.87 18 0.45 0.28 0.34 0.61 
DIETSUPP 44 0.91 0.89 0.90 42 0.88 0.90 0.89 0.90 
M.-DIABETES 43 0.90 0.86 0.88 43 0.87 0.91 0.89 0.88 
MI-6MOS 8 0.67 0.50 0.57 78 0.95 0.97 0.96 0.77 
Rule-based CREATININE 24 0.87 0.83 0.85 62 0.93 0.95 0.94 0.90 
HBA1C 35 1.00 0.77 0.87 51 0.86 1.00 0.93 0.90 
ENGLISH 73 0.94 0.99 0.96 13 0.89 0.62 0.73 0.84 
M.-DECISION 83 0.96 0.98 0.97 3 0.00 0.00 0.00 0.49 
 overall (micro) - 0.88 0.90 0.89 - 0.93 0.92 0.92 0.9069 
 overall (macro) - 0.79 0.73 0.75 - 0.81 0.78 0.79 0.80955 
Class 
Tannier et al. – Hybrid Approaches for Cohort Selection for Clinical Trials 
 
positive and negative examples (Section 4.2) where possible, that is, both classes are sometimes made 
explicit in the reports; a weakly supervised approach like those of Agarwal et al. [18] or 
Halpern et al. [17] when the negative examples are implicit. 
Finally, note that the metrics used during the challenge and this article (especially F1-measure) mask 
that fact that a very high recall is expected from these systems, in order to guarantee that only few 
patients are missed and that the system can be validated as an efficient filter before human 
intervention. Rule-based systems are generally more precise than sensitive.  
 
7. CONCLUSION AND PERSPECTIVES 
There is still a way to go to get tools able to identify a wide range of patient phenotypes for cohort 
selection, or even to help the researcher build cohorts faster and with less potential bias. In this paper, 
we have outlined approaches for the generalization of the process, with results as good as fully hand-
crafted rule-based systems.  
Building the n2c2 dataset used in our work has been a huge effort, and the organizers must be thanked 
for this. However, we cannot expect more data on many more criteria to be produced in the near 
future. The effort must now focus on creating weakly or non-supervised methods able to actively 
assist the medical researchers, to transfer a model from a phenotype to another or to learn generic 
patient representations.  
Moreover, next generation phenotyping requires methods allowing the joint exploitation of structured 
and unstructured data. Using all available information and knowledge seems to be a necessary 
condition for getting closer to the performance of a human expert for patient selection. The 
exploitation of such heterogeneous data is a challenge, but recent advances in the field of information 
representation, notably thanks to neural networks, show that all types of structure can be represented 
in the same space, allowing the implementation of algorithms on a single mode of representation from 
multiple sources. This type of approaches has been applied, for example, to the joint representation 
of images and text [39], knowledge bases and texts [40], and very recently patients with structured 
data and text [41]. 
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